Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Nisreen M.A. Okba"'
Autor:
Jordi Rodon, Anna Z. Mykytyn, Nigeer Te, Nisreen M.A. Okba, Mart M. Lamers, Lola Pailler-García, Guillermo Cantero, Irina Albulescu, Berend-Jan Bosch, Malik Peiris, Albert Bensaid, Júlia Vergara-Alert, Bart L. Haagmans, Joaquim Segalés
Publikováno v:
Emerging Infectious Diseases, Vol 29, Iss 3, Pp 585-589 (2023)
Middle East respiratory syndrome coronavirus (MERS-CoV) clade B viruses are found in camelids and humans in the Middle East, but clade C viruses are not. We provide experimental evidence for extended shedding of MERS-CoV clade B viruses in llamas, wh
Externí odkaz:
https://doaj.org/article/3df57913f36e427cb3de1a017c369387
Autor:
Nisreen M.A. Okba, Marcel A. Müller, Wentao Li, Chunyan Wang, Corine H. GeurtsvanKessel, Victor M. Corman, Mart M. Lamers, Reina S. Sikkema, Erwin de Bruin, Felicity D. Chandler, Yazdan Yazdanpanah, Quentin Le Hingrat, Diane Descamps, Nadhira Houhou-Fidouh, Chantal B.E.M. Reusken, Berend-Jan Bosch, Christian Drosten, Marion P.G. Koopmans, Bart L. Haagmans
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 7, Pp 1478-1488 (2020)
A new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently emerged to cause a human pandemic. Although molecular diagnostic tests were rapidly developed, serologic assays are still lacking, yet urgently needed. Vali
Externí odkaz:
https://doaj.org/article/efaa47224f7f477981d2304a96d84325
Autor:
Nisreen M.A. Okba, Ivy Widjaja, Wentao Li, Corine H. GeurtsvanKessel, Elmoubasher A.B.A. Farag, Mohammed Al-Hajri, Wan Beom Park, Myoung-don Oh, Chantal B.E.M. Reusken, Marion P.G. Koopmans, Berend-Jan Bosch, Bart L. Haagmans
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 5, Pp 1024-1027 (2020)
We developed and validated 2 species-independent protein-based assays to detect Middle East respiratory syndrome coronavirus functional antibodies that can block virus receptor-binding or sialic acid-attachment. Antibody levels measured in both assay
Externí odkaz:
https://doaj.org/article/c5b0fabb442c4db7924db49ec4ec268c
Autor:
Elmoubasher Farag, Reina S. Sikkema, Ahmed A. Mohamedani, Erwin de Bruin, Bas B. Oude Munnink, Felicity Chandler, Robert Kohl, Anne van der Linden, Nisreen M.A. Okba, Bart L. Haagmans, Judith M.A. van den Brand, Asia Mohamed Elhaj, Adam D. Abakar, Bakri Y.M. Nour, Ahmed M. Mohamed, Bader Eldeen Alwaseela, Husna Ahmed, Mohd Mohd Alhajri, Marion Koopmans, Chantal Reusken, Samira Hamid Abd Elrahman
Publikováno v:
Emerging Infectious Diseases, Vol 25, Iss 12, Pp 2333-2335 (2019)
We tested samples collected from camels, camel workers, and other animals in Sudan and Qatar in 2015 and 2017 for evidence of Middle East respiratory syndrome coronavirus (MERS-CoV) infection. MERS-CoV antibodies were abundant in Sudan camels, but we
Externí odkaz:
https://doaj.org/article/da29e8b792c046308e6622c9a2c8c616
Autor:
Nisreen M.A. Okba, V. Stalin Raj, Ivy Widjaja, Corine H. Geurts van Kessel, Erwin de Bruin, Felicity D. Chandler, Wan Beom Park, Nam-Joong Kim, Elmoubasher A.B.A. Farag, Mohammed Al-Hajri, Berend-Jan Bosch, Myoung-don Oh, Marion P.G. Koopmans, Chantal B.E.M. Reusken, Bart L. Haagmans
Publikováno v:
Emerging Infectious Diseases, Vol 25, Iss 10, Pp 1868-1877 (2019)
Middle East respiratory syndrome coronavirus (MERS-CoV) infections in humans can cause asymptomatic to fatal lower respiratory lung disease. Despite posing a probable risk for virus transmission, asymptomatic to mild infections can go unnoticed; a la
Externí odkaz:
https://doaj.org/article/a91442a9b5ec420281b9af89224899cf
Autor:
Ivy Widjaja, Chunyan Wang, Rien van Haperen, Javier Gutiérrez-Álvarez, Brenda van Dieren, Nisreen M.A. Okba, V. Stalin Raj, Wentao Li, Raul Fernandez-Delgado, Frank Grosveld, Frank J. M. van Kuppeveld, Bart L. Haagmans, Luis Enjuanes, Dubravka Drabek, Berend-Jan Bosch
Publikováno v:
Emerging Microbes and Infections, Vol 8, Iss 1, Pp 516-530 (2019)
ABSTRACTThe Middle-East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic virus that causes severe and often fatal respiratory disease in humans. Efforts to develop antibody-based therapies have focused on neutralizing antibodies that target
Externí odkaz:
https://doaj.org/article/c5a58e9203e14de48fe994d1b6032c31
Autor:
Dan David, Ditza Rotenberg, Evgeny Khinich, Oran Erster, Svetlana Bardenstein, Michael van Straten, Nisreen M.A. Okba, Stalin V. Raj, Bart L. Haagmans, Marcelo Miculitzki, Irit Davidson
Publikováno v:
One Health, Vol 5, Iss , Pp 65-68 (2018)
Thus far, no human MERS-CoV infections have been reported from Israel. Evidence for the circulation of MERS-CoV in dromedaries has been reported from almost all the countries of the Middle East, except Israel. Therefore, we aimed to analyze MERS-CoV
Externí odkaz:
https://doaj.org/article/19010d8e000a4a83a2bfc09329b18b18
Publikováno v:
One Health, Vol 3, Iss C, Pp 11-16 (2017)
Middle East respiratory syndrome coronavirus (MERS-CoV) still causes outbreaks despite public awareness and implementation of health care measures, such as rapid viral diagnosis and patient quarantine. Here we describe the current epidemiological pic
Externí odkaz:
https://doaj.org/article/e5c35ade0bc14bddb4e5f24333cacd6d
Autor:
Lonneke M. Leijten, Bart L. Haagmans, Brigitta M. Laksono, Bart J. A. Rijnders, Corine H. GeurtsvanKessel, Rob van Binnendijk, Zsofia Igloi, Nisreen M.A. Okba, Susanne Bogers, Casper Rokx, Carmen W.E. Embregts, Annemiek A. van der Eijk, Johannes P. C. van den Akker, Marion Koopmans, Janette Rahamat-Langendoen, Jeroen J. A. van Kampen
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-5 (2020)
Nature Communications, 11(1):3436. Nature Publishing Group
Nature Communications, 11, 1
Nature Communications, 11
Nature Communications
Nature Communications, 11(1):3436. Nature Publishing Group
Nature Communications, 11, 1
Nature Communications, 11
Nature Communications
The world is entering a new era of the COVID-19 pandemic in which there is an increasing call for reliable antibody testing. To support decision making on the deployment of serology for either population screening or diagnostics, we present a detaile
Autor:
Asisa Volz, Thomas Hesterkamp, Anahita Fathi, Markus Eickmann, Cornelius Rohde, Saskia Borregaard, Stefan Schmiedel, Gerd Sutter, Christine Dahlke, Robert Fux, Madeleine E Zinser, Joseph S H Poetsch, Sandro Halwe, Reza Neumann, Etienne Bartels, Nisreen M.A. Okba, Alen Jambrecina, My L Ly, Bart L. Haagmans, Till Koch, Marylyn M. Addo, Alexandra Kupke, Stephan Becker, Verena Krähling, Ansgar W. Lohse
Publikováno v:
Lancet Infectious Diseases, 20(7), 827-838. Lancet Publishing Group
Summary Background The Middle East respiratory syndrome coronavirus (MERS-CoV) causes a respiratory disease with a case fatality rate of up to 35%. Given its potential to cause a public health emergency and the absence of efficacious drugs or vaccine